Safety and Efficacy of Tree Pollen Specific Immunotherapy on the Ultrarush Administration Schedule Method Using Purethal Trees

Table 2

Study groups characteristics.

	Group A	Group B	𝑃
Age	20.9±4.2	21.9±3.2	NS
Men/women	6/4	6/6	NS
Disease duration	4.7±1.5	4.9±1.3	NS
Mean score of nasal symptoms before SIT	3.991±0.804	3.845±0.265	NS
Mean score of other symptoms before SIT	4.127±0.652	4.011±0.407	NS
Mean drug use score in the season one year before SIT	1.661±0.445	1.788±0.652	NS
Serum concentration of total IgE	402.78±54.8	387.66±74.61	NS
Serum concentration of sIgE to birch	32.72±8.77	35.33±6.87	NS
Serum concentration of sIgE to alder	15.92±3.91	18.73±4.61	NS
Serum concentration of sIgE to hazel	28.55±6.12	30.34±5.88	NS

sIgE: specific IgE; SIT: specific immunotherapy; NS: not statistically significant.